WVE NASDAQ
Wave Life Sciences Ltd.
1W: +0.9%
1M: -6.0%
3M: -40.6%
YTD: -78.4%
1Y: -51.6%
3Y: -37.4%
5Y: -26.4%
$3.45
+0.24 (+7.48%)
Weekly Expected Move ±7.7%
$3
$3
$3
$3
$4
Credit Risk of going bust: higher than 79% of companies Debt: 6.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.05 (down 99%), Wave Life Sciences Ltd. would be worth roughly what it owes.
Total debt $43.3M against a stock market value of $680.4M.
Distance to default 2.65 (Merton model): prices to 2026-10-27, balance sheet 2026-09-30, debt counted $23.8M (short-term plus half of long-term), stock volatility 111.1%; Altman Z'' -56.95. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.05 (down 99%), Wave Life Sciences Ltd. would be worth roughly what it owes.
Total debt $43.3M against a stock market value of $680.4M.
Distance to default 2.65 (Merton model): prices to 2026-10-27, balance sheet 2026-09-30, debt counted $23.8M (short-term plus half of long-term), stock volatility 111.1%; Altman Z'' -56.95. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
4 bullish
0 neutral
0 bearish
Articles (24h)
4
Hourly Sentiment (24h)
Articles (4)
0.39
Bullish
4 bullish
2 neutral
1 bearish
Articles (7d)
7
Daily Sentiment (7 Days)
Articles (100)
Wave plans post-incretin maintenance trial in Q4 as cash runway extends into Q3 2028
Wave Life Sciences (WVE) Q3 2026 Earnings Call Transcript
Wave Life Sciences (WVE) Reports Q3 Loss, Tops Revenue Estimates
Wave Life Sciences GAAP EPS of -$0.30 beats by $0.03, revenue of $13.16M beats by $8.77M
Here are the major earnings before the open Tuesday
Wave Life Sciences Q3 2026 Earnings Preview
Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for
WAVE Life Sciences (NASDAQ:WVE) Sets New 1-Year Low – Here’s Why
WAVE Life Sciences (NASDAQ:WVE) Shares Climb 9.3% – Here’s What Happened
WAVE Life Sciences (NASDAQ:WVE) Shares Gap Up – Time to Buy?
Wave Life jumps as FDA backs registrational plans for AATD therapy
Wave to receive $12M milestone as GSK picks liver candidate
Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development
4 RNA Therapeutics Stocks Leading the Next Wave of Innovation
Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity
WAVE Life Sciences (NASDAQ:WVE) Sets New 12-Month Low – Time to Sell?
WAVE Life Sciences (NASDAQ:WVE) Stock Price Down 6.8% - Should You Sell? - MarketBeat
WAVE Life Sciences: Target Price Consensus and Analysts Recommendations | WVE | US94352A1043 - marketscreener.com
WAVE Life Sciences: Top Mutual Funds Holders | WVE | US94352A1043 - marketscreener.com
WAVE Life Sciences: Performance & Quotes, WVE Stock Price on Nasdaq Exchange - marketscreener.com
WVE Dec 2026 11.000 put (WVE261218P00011000) stock historical prices and data - uk.finance.yahoo.com
WAVE Life Sciences (NASDAQ:WVE) Shares Gap Up - Here's Why - MarketBeat
WVE Looks 39.7% Overvalued on GF Value™ - GuruFocus
Wave Life Sciences Keeps WVE Ticker After Delaware Parent Move - Stock Titan
Analysts Just Made A Major Revision To Their Wave Life Sciences Ltd. (NASDAQ:WVE) Revenue Forecasts - simplywall.st
WAVE Life Sciences Ltd. (NASDAQ:WVE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Wave Life Sciences Ltd. SEC Filing (Aug 7, 2026) - Stock Titan
Wave Life Sciences (WVE) files prospectus for 7.1M-share stockholder resale - Stock Titan
Wave Life Sciences (WVE) refreshes $250M ATM and shelf after Delaware redomicile - Stock Titan
Did U.S. Redomiciliation and Mixed 1H 2026 Results Just Shift Wave Life Sciences' (WVE) Investment Narrative?
WAVE Life Sciences Ltd. $WVE Shares Purchased by Renaissance Technologies LLC - MarketBeat
Wave Life Sciences Announces Expected Completion Date for Redomiciliation to Delaware
Singapore High Court approves scheme for Wave Life Sciences’ Delaware move - Stock Titan
Wave Life Sciences CEO to Join Two Live Investor Webcasts - Stock Titan
Wave Life Sciences to Present at Upcoming Investor Conferences
Wave Life Sciences (WVE) Q2 2026 Earnings Call Transcript
Wave Life Sciences (WVE) Q2 2026 Earnings Call Transcript
Wave Life Sciences (WVE) Stock Sinks As Losses Deepen And Revenue Dries Up - simplywall.st
Wave Life Sciences (WVE) Q2 2026 Earnings Call Transcript
Wave Life Sciences Ltd. Q2 2026 Earnings Call Summary
WAVE Life Sciences Q2 Earnings Call Highlights
WAVE Life Sciences Ltd (WVE) (Q2 2026) Earnings Call Highlights: Strong Cash Position and ...
Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates
Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates
Takeda Pharmaceutical Q1 Earnings Call Highlights
Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Wave Life Sciences Q2 2026 Earnings Preview
Wave Life Sciences (WVE) Stock Looks Cheap On Price But Expensive On Sales
Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026
Wave Life Sciences (WVE) Stock Looks Cheap On Price But Expensive On Sales - Yahoo Finance
Wave Life Sciences (WVE) Upgraded to Strong Buy: What Does It Mean for the Stock?
Wave Life Sciences (WVE) Upgraded to Strong Buy: What Does It Mean for the Stock?
SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat?
New Strong Buy Stocks for July 22nd
New Strong Buy Stocks for July 22nd
3 Promising Genomics Stocks to Add to Your Portfolio in 2026
3 Promising Genomics Stocks to Add to Your Portfolio in 2026
Is QURE Stock Attractive After Its Rally, Rich Valuation, and Hold?
QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway
QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway
MeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last?
Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation
Does Wave Life Sciences (WVE) Have the Potential to Rally 294.66% as Wall Street Analysts Expect?
Wave Life Sciences (WVE) Upgraded to Buy: Here's Why
Strength Seen in Intellia Therapeutics (NTLA): Can Its 23.2% Jump Turn into More Strength?
Is Wave Life Sciences Ltd. (WVE) A Good Stock To Buy Now?
Is Wave Life Sciences Ltd. (WVE) A Good Stock To Buy Now? - Yahoo Finance
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter
Wave Life Sciences Ltd. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
WVE Stock Edges Up After Positive Early Data For Rare Disease Drug - Stocktwits
Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
ARWR: Multiple Important Clinical Readouts in 2H26
Wave (WVE) Q1 2026 Earnings Call Transcript
Wave (WVE) Q2 2025 Earnings Call Transcript
Wave (WVE) Q1 2025 Earnings Call Transcript
Wave Life Sciences (WVE) Reports Q1 Loss, Beats Revenue Estimates
Wave Life Sciences GAAP EPS of -$0.13 beats by $0.19, revenue of $38.25M beats by $30.33M
Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
Earnings Scheduled For April 28, 2026
Here are the major earnings before the open Tuesday
Wave Life Sciences Ltd. (WVE) Sees Strong Buy Rating From Analysts
Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026
Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States
What is HC Wainwright’s Forecast for WVE FY2027 Earnings?
WAVE Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of “Moderate Buy” from Analysts
My Thesis On $WVE. RA Capital bought $54M after a 50% crash in this Ozempic Competitor.
Is This Weight Loss Drug Stock a Buy on the Dip?
Wave Life Sciences (WVE) Surges 9.5%: Is This an Indication of Further Gains?
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
WAVE Life Sciences (NASDAQ:WVE) Hits New 12-Month Low – What’s Next?
WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks
Stock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data Disappoints
Wave hits 52-week low as analysts react to obesity drug data
12 Health Care Stocks Moving In Thursday's Intraday Session
Crude Oil Gains 4%; Commercial Metals Posts Mixed Q2 Results
Why Is Wave Life Sciences Stock Falling After Weight Loss Study Data?
WAVE LIFE SCIENCES Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses